By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Abbott today announced the expansion of an agreement with GlaxoSmithKline Biologicals for the development of an additional companion diagnostic test for GSK's cancer immunotherapy research program.
Already have a GenomeWeb or 360Dx account?Login Now.
An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.
In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.
Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.
This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.